Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cencora (COR – Research Report) and Morphosys Ag (MOR – Research Report).
Cencora (COR)
In a report released today, Steve Baxter from Wells Fargo maintained a Hold rating on Cencora, with a price target of $235.00. The company’s shares closed last Monday at $234.79, close to its 52-week high of $237.47.
According to TipRanks.com, Baxter is a 3-star analyst with an average return of
Cencora has an analyst consensus of Strong Buy, with a price target consensus of $243.50, representing a 2.6% upside. In a report released today, Mizuho Securities also maintained a Hold rating on the stock with a $224.00 price target.
See the top stocks recommended by analysts >>
Morphosys Ag (MOR)
Wells Fargo analyst Derek Archila maintained a Buy rating on Morphosys Ag today and set a price target of $17.00. The company’s shares closed last Monday at $16.31.
According to TipRanks.com, Archila is a 4-star analyst with an average return of
Currently, the analyst consensus on Morphosys Ag is a Strong Buy with an average price target of $13.23.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on COR:
